Related Experiment Video
Updated: Mar 28, 2026

Identification of OTX1 and OTX2 As Two Possible Molecular Markers for Sinonasal Carcinomas and Olfactory Neuroblastomas
Published on: February 28, 2019
The role of HOX genes in head and neck squamous cell carcinoma
Christopher Platais1, Fahad Hakami1,2, Lav Darda1
1Unit of Oral and Maxillofacial Pathology, School of Clinical Dentistry, University of Sheffield, Sheffield, UK.
Abstract:
Recent decades have witnessed the publication of numerous studies reporting alterations in the genome and transcriptome of head and neck squamous cell carcinoma (HNSCC). Currently, the utilisation of these alterations as biomarkers and targets for therapy is limited and new, useful molecular characteristics are being sought. Many of the published HNSCC gene expression profiles demonstrate alterations in the expression of HOX genes. These are a family of Homeobox-containing genes which are involved in developmental patterning and morphogenesis in the embryo, and which are often aberrantly expressed in cancer. The 39 HOX genes found in the human genome are arranged in four paralogous groups at different chromosomal loci. These control a wide range of cellular processes, including proliferation and migration, which are relevant in the context of cancer development. In this review article, we will outline the biology of HOX genes in relation to cancer and summarise the accumulating evidence for their role in the development of HNSCC and the possibility that they could be a therapeutic target in this malignancy. We will also identify areas where our current understanding is weak to focus future work and appraise the ongoing strategies for pharmacological intervention.
Insights
HOX genes, crucial in embryonic development, are frequently altered in head and neck squamous cell carcinoma (HNSCC). Research suggests HOX genes may serve as novel biomarkers and therapeutic targets for HNSCC treatment.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Head and neck squamous cell carcinoma (HNSCC) exhibits numerous genomic and transcriptomic alterations.
- Current therapeutic targets and biomarkers for HNSCC are limited, necessitating the identification of new molecular characteristics.
- Aberrant expression of HOX genes, involved in embryonic development, is frequently observed in HNSCC gene expression profiles.
Purpose of the Study:
- To review the biology of HOX genes in cancer.
- To summarize evidence for HOX gene involvement in HNSCC development.
- To evaluate HOX genes as potential therapeutic targets for HNSCC.
Main Methods:
- Literature review of studies on HOX gene expression in HNSCC.
- Analysis of the role of HOX genes in cellular processes relevant to cancer.
- Appraisal of current and future pharmacological interventions targeting HOX genes.
Main Results:
- HOX genes are implicated in developmental patterning and morphogenesis.
- Aberrant HOX gene expression is a common feature in HNSCC.
- HOX genes regulate cellular proliferation and migration, processes critical in cancer development.
Conclusions:
- HOX genes play a significant role in HNSCC development.
- HOX genes represent promising candidates for novel HNSCC biomarkers and therapeutic targets.
- Further research is needed to elucidate specific HOX gene functions and optimize pharmacological strategies.
More Related Videos
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
07:52In Vivo CRISPR/Cas9 Screening to Simultaneously Evaluate Gene Function in Mouse Skin and Oral Cavity
Published on: November 2, 2020
Related Concept Videos
Hedgehog Signaling Pathway
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...